Estudio bibliométrico sobre el impacto de los medicamentos biosimilares

  1. Peralta, Sebastián 1
  2. Ruiz, María Adolfina 1
  3. María Encarnación Morales
  1. 1 Universidad de Granada
    info

    Universidad de Granada

    Granada, España

    ROR https://ror.org/04njjy449

Journal:
Ars pharmaceutica

ISSN: 2340-9894,  0004-2927

Year of publication: 2017

Volume: 58

Issue: 3

Pages: 103-106

Type: Article

DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Ars pharmaceutica

Abstract

Objectives: A bibliometrics study is a type of statistical study on scientific data. With this tool we want to visualize different aspects of biosimilar drugs, their importance and the impact they generate in their environment. Methods: Science Direct was utilized as a search engine, in addition to the scientific publications referenced in the bibliography as well as some websites concerning the subject. Results: Almost all the indicators point to the great economic importance of biosimilar drugs, their novelty and their patient-coentered focus. Conclusions: It is of great interest to know the future impact that these medicines will have and the repercussions they will bring, especially in the economic and health fields.

Bibliographic References

  • Mingersa J, Leydesdorffb L. A review of theory and practice in scientometrics. Eur J Oper Res. 2015; 246(1):1-19.
  • Calvo B, Zúñiga L, Gómez P. Evaluación de la biosimilitud y comparabilidad de medicamentos biosimilares. Ars Pharm. 2013; 54(4):32-36.
  • Villamañán E, González D, Armada E, Ruano M, Álvarez-Sala R, Herrero A. Juego de patentes. Sobre medicamentos genéricos y biosimilares. The patents game. Generic and biosimilar drugs. Rev Calid Asist. 2016; 31(2):99-105.
  • Schimizzi G.F. Biosimilars from a practicing rheumatologist perspective: An overview. Autoimmun Rev. 2016; 15(9):911-916
  • Flyvbjerg H. Biomathematics. Mathematics of Biostructures and Biodynamics. Chem Phys Lipids. 2000; 106(2):191-192.
  • Romain O. Preud'homme D. Actualités pharmaceutiques. Arch Pediatr. 2007; 14(10):1274-1277.
  • Blog biosim. Asociación Española de biosimilares. [consultado el10/8/2017]. Disponible en: http://www.biosim.es/blog/
  • Girault D, Trouvin JH, Blachier-Poisson C, Gary F, Laloye D. Biosimilars: from Technical to Pharmacoeconomic Considerations. Ther. 2015; 70(1):47-55.
Data source: Dialnet